Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC5R | P33032 | 2/20 | 0.56 |
| ▸ | MC3R | P41968 | 2/20 | 0.56 |
| ▸ | MC1R | Q01726 | 2/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | G6PD | P11413 | 1/20 | 0.47 |
| ▸ | KCNT1 | Q5JUK3 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 3/20 | 0.46 |
| ▸ | HTR6 | P50406 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 2/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | HTR7 | P34969 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23745649 | 0.84 | MC5R (0.56) | MC5RMC3RMC1RHRH3BCHE | |
| SCHEMBL23745438 | 0.83 | MC5R (0.55) | MC5RMC3RMC1RHRH3BCHE | |
| Hydrochloric Acid SCHEMBL23721953 | 0.82 | MC5R (0.54) | MC5RMC3RMC1RHRH3BCHE | |
| SCHEMBL23745646 | 0.81 | MC5R (0.68) | MC5RMC3RMC1RG6PDKCNT1 | |
| Hydrochloric Acid SCHEMBL23722043 | 0.80 | MC5R (0.67) | MC5RMC3RMC1RBCHEG6PD | |
| SCHEMBL798249 | 0.74 | MC1R (1.00) | MC5RMC3RMC1RG6PDKCNT1 | |
| SCHEMBL23745515 | 0.73 | MC5R (0.53) | MC5RMC3RMC1RHRH3KCNT1 | |
| Hydrochloric Acid SCHEMBL23722019 | 0.73 | MC5R (0.52) | MC5RMC3RMC1RHRH3KCNT1 | |
| SCHEMBL9299174 | 0.70 | HTR2A (0.70) | MC5RMC3RMC1RHRH3BCHE | |
| SCHEMBL17232881 | 0.70 | MC5R (0.83) | MC5RMC3RMC1RBCHEG6PD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | MC5R 3934/4885MC3R 4252/4885MC1R 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.